Buyer Name: NHS England
Buyer Address: 2nd Floor Rutland House, Runcorn, WA7 2ES, GB
Contact Name: Lynne Tierney
Contact Email: lynne.tierney@nhs.net
Buyer Name: NHS England
Buyer Address: 2nd Floor Rutland House, Runcorn, WA7 2ES, GB
Contact Name: Lynne Tierney
Contact Email: lynne.tierney@nhs.net
NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 Offer reference number: CM/PHR/24/5680 CM/PHR/24/5680/01 - NHS Framework Agreement for Branded Medicines - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 CM/PHR/24/5680/02 - NHS Framework Agreement for Branded Medicines - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026 Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk
External Link: https://www.contractsfinder.service.gov.uk/Notice/8c603c5e-25d4-4ab4-8bb9-504458a54727
Link Description: Opportunity notice on Contracts Finder
Document Description: Opportunity notice on Contracts Finder
Document Description: Document No. 05c - Volume Discounts or Additional Products Offer Schedule - CM-PHR-24-5680
Document Description: Document No. 09 - Tender Design and Instructions on Completing the Offer Schedule
Document Description: Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements
Document Description: Document No. 07a - Quality Control Technical Sheet
Document Description: Document No. 07b - Quality Assurance Policy to Support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023)
Document Description: Document No. 08 - Confidential Information Schedule - CM_PHR_24_5680
Document Description: Document No. 05 - Selectt Offer Schedule Instructions - CM-PHR-24-5680
Document Description: Document No. 06 - Form of Offer - CM_PHR_24_5680
Document Description: Document No. 05a(ii) - Selectt Offer Schedule - CM_PHR_24_5680_02
Document Description: Document No. 10 - Participating Authorities - CM_PHR_24_5680
Document Description: Document No. 02 - Terms of offer
Document Description: Document No. 04a - Quality Assurance Process
Document Description: Document No. 05a(i) - Selectt Offer Schedule - CM_PHR_24_5680_01
Document Description: Document No. 05b(i) - Tender Product Listing and Usage - CM_PHR_24_5680_01
Document Description: Document No. 03 - Framework Agreement and Terms and Conditions - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab - 1 September 2025
Document Description: Document No. 01 - Invitation to offer covering letter
Document Description: Document No. 05b(ii)- Tender Product Listing and Usage - CM_PHR_24_5680_02
{
"buyer": {
"id": "GB-CFS-156205",
"name": "NHS England"
},
"date": "2025-02-17T10:24:38Z",
"id": "8c603c5e-25d4-4ab4-8bb9-504458a54727-826898",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-b5fd17-1266d8b9-9f94-4443-a0a5-21d13bc7faa8",
"parties": [
{
"address": {
"countryName": "GB",
"locality": "Runcorn",
"postalCode": "WA7 2ES",
"streetAddress": "2nd Floor Rutland House"
},
"contactPoint": {
"email": "lynne.tierney@nhs.net",
"name": "Lynne Tierney"
},
"id": "GB-CFS-156205",
"identifier": {
"legalName": "NHS England"
},
"name": "NHS England",
"roles": [
"buyer"
]
}
],
"tag": [
"tender"
],
"tender": {
"classification": {
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
},
"contractPeriod": {
"endDate": "2027-08-31T23:59:59+01:00",
"startDate": "2025-09-01T00:00:00+01:00"
},
"datePublished": "2025-02-17T10:24:38Z",
"description": "NHS Framework Agreement for Branded Medicines - Tranche B - NOFE \u0026 MAE and Eculizumab \u0026 Ravulizumab for London \u0026 SOFE - 01 September 2025\r\n\r\nOffer reference number: CM/PHR/24/5680\r\n\r\nCM/PHR/24/5680/01 - NHS Framework Agreement for Branded Medicines - Tranche B for North of England and Midlands \u0026 East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 \r\n\r\nCM/PHR/24/5680/02 - NHS Framework Agreement for Branded Medicines - Eculizumab and Ravulizumab for London \u0026 SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026\r\n\r\nAdditional information: \r\nTo express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.\r\n\r\nShould Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:\r\n\r\nPhone: 0800 9956035\r\n\r\nE-mail: support-health@atamis.co.uk",
"documents": [
{
"datePublished": "2025-02-17T10:24:38Z",
"description": "Opportunity notice on Contracts Finder",
"documentType": "tenderNotice",
"format": "text/html",
"id": "1",
"language": "en",
"url": "https://www.contractsfinder.service.gov.uk/Notice/8c603c5e-25d4-4ab4-8bb9-504458a54727"
},
{
"description": "Document No. 05c - Volume Discounts or Additional Products Offer Schedule - CM-PHR-24-5680",
"format": "application/vnd.ms-excel",
"id": "2",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/500d0357-4e34-49e9-8f49-c1fe42ca194a"
},
{
"description": "Document No. 09 - Tender Design and Instructions on Completing the Offer Schedule",
"format": "application/msword",
"id": "3",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/83591f74-3c5c-4b30-ae8e-8c83aca3f6b3"
},
{
"description": "Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements",
"format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
"id": "4",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/e5189dcb-18c5-4ed5-bc6f-09ba3312878d"
},
{
"description": "Document No. 07a - Quality Control Technical Sheet",
"format": "application/msword",
"id": "5",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/ae998b4a-8561-4fdd-ad28-94a82e109ed7"
},
{
"description": "Document No. 07b - Quality Assurance Policy to Support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023)",
"format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
"id": "6",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/f11397c9-5736-4cb9-9c8a-884fec6a3951"
},
{
"description": "Document No. 08 - Confidential Information Schedule - CM_PHR_24_5680",
"format": "application/vnd.ms-excel",
"id": "7",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/a3d30f4c-b6a4-4318-96f3-4f244e2b992c"
},
{
"description": "Document No. 05 - Selectt Offer Schedule Instructions - CM-PHR-24-5680",
"format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
"id": "8",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/85742564-f360-483e-8942-367e0c6afb0f"
},
{
"description": "Document No. 06 - Form of Offer - CM_PHR_24_5680",
"format": "application/msword",
"id": "9",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/81318c8d-6877-4411-ac69-1ef3f4b338bd"
},
{
"description": "Document No. 05a(ii) - Selectt Offer Schedule - CM_PHR_24_5680_02",
"format": "application/xml",
"id": "10",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/c86b9b72-226e-4f9c-8e0e-54a326f9bb72"
},
{
"description": "Document No. 10 - Participating Authorities - CM_PHR_24_5680",
"format": "application/vnd.ms-excel",
"id": "11",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/f6f94dd0-9fcd-46e3-afd5-6bb2619b215f"
},
{
"description": "Document No. 02 - Terms of offer",
"format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
"id": "12",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/8fa3ba33-e9d7-481f-a205-40e5b3c1a256"
},
{
"description": "Document No. 04a - Quality Assurance Process",
"format": "application/msword",
"id": "13",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/2edeaa5f-49c9-4731-940a-ce510688056e"
},
{
"description": "Document No. 05a(i) - Selectt Offer Schedule - CM_PHR_24_5680_01",
"format": "application/xml",
"id": "14",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/1688a671-4dfd-4480-bf73-c44d3a8e66aa"
},
{
"description": "Document No. 05b(i) - Tender Product Listing and Usage - CM_PHR_24_5680_01",
"format": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
"id": "15",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/e6f16247-d34d-4535-a6b3-c627f0bdf10e"
},
{
"description": "Document No. 03 - Framework Agreement and Terms and Conditions - Tranche B - NOFE \u0026 MAE and Eculizumab \u0026 Ravulizumab - 1 September 2025",
"format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
"id": "16",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/fe801f8a-52d4-4ab1-86f5-d1df6ee37cc7"
},
{
"description": "Document No. 01 - Invitation to offer covering letter",
"format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
"id": "17",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/b757934f-8cb0-4393-942d-c7f7af2826cb"
},
{
"description": "Document No. 05b(ii)- Tender Product Listing and Usage - CM_PHR_24_5680_02",
"format": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
"id": "18",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/508b8d94-ee62-43ad-a938-d8fe3d4eb211"
}
],
"id": "CF-2825700D0O000000rwimUAA",
"items": [
{
"deliveryAddresses": [
{
"countryName": "United Kingdom",
"region": "East Midlands"
},
{
"countryName": "United Kingdom",
"region": "East of England"
},
{
"countryName": "United Kingdom",
"region": "London"
},
{
"countryName": "United Kingdom",
"region": "North East"
},
{
"countryName": "United Kingdom",
"region": "North West"
},
{
"countryName": "United Kingdom",
"region": "South East"
},
{
"countryName": "United Kingdom",
"region": "South West"
},
{
"countryName": "United Kingdom",
"region": "West Midlands"
},
{
"countryName": "United Kingdom",
"region": "Yorkshire and the Humber"
}
],
"id": "1"
}
],
"mainProcurementCategory": "goods",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure (above threshold)",
"status": "active",
"suitability": {
"sme": true,
"vcse": false
},
"tenderPeriod": {
"endDate": "2025-04-07T13:00:00+01:00"
},
"title": "NHS Framework Agreement for Branded Medicines - Tranche B - NOFE \u0026 MAE and Eculizumab \u0026 Ravulizumab for London \u0026 SOFE - 01 September 2025",
"value": {
"amount": 2028332000,
"currency": "GBP"
}
}
}